AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring scale and speed. Humans bring intuition, context and accountability.

For the past decade, Dr. Priscilla Chan and her husband Mark Zuckerberg have focused part of their philanthropy on a lofty goal — “to cure, prevent or manage all disease” — if not in their lifetime, t

Caris Life Sciences, Inc. ( ($CAI) ) has released its Q3 earnings. Here is a breakdown of the information Caris Life Sciences, Inc. presented to

Frontier’s Wilmington hub will anchor North American operations, with Shannon, Ireland, leading efforts in Europe, the Middle East and Africa.

Biotech Evommune and diagnostics startup BillionToOne will begin trading today, with venture investors avid to see public markets fully embrace the sector again.

BioLife Science aims to redefine what a wellness center can be by creating an environment that feels like a spa rather than a clinic.

Shares of Lantheus Holdings declined after the radiopharmaceutical company’s second-quarter earnings results and guidance fell short of expectations. Read more here.

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence,

For centuries, humans have looked to the stars, the oceans, and even the tiniest cells to answer one impossible question: why does life exist at all? From philosophers to physicists, theories have ranged from divine design to cosmic accidents—but new scientific discoveries are bringing us closer than ever to understanding life’s true origins.